{
    "2019-06-05": [
        [
            {
                "time": "2019-06-05",
                "original_text": "Blueprint Medicines to File NDA for Avapritinib With FDA",
                "features": {
                    "keywords": [
                        "Blueprint Medicines",
                        "NDA",
                        "Avapritinib",
                        "FDA"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-05",
                "original_text": "Jeff Settleman, Ph.D., Joins Pfizer to Lead Oncology Research & Development",
                "features": {
                    "keywords": [
                        "Jeff Settleman",
                        "Pfizer",
                        "Oncology",
                        "Research & Development"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-05",
                "original_text": "Top Tips for Long-Term Stock Investors",
                "features": {
                    "keywords": [
                        "Long-Term",
                        "Stock Investors",
                        "Tips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-05",
                "original_text": "How Merck reached new ground in the fight against cancer",
                "features": {
                    "keywords": [
                        "Merck",
                        "cancer",
                        "fight",
                        "new ground"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-05",
                "original_text": "The Zacks Analyst Blog Highlights: Pfizer, Coca-Cola, VMware, NIKE and AIG",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Pfizer",
                        "Coca-Cola",
                        "VMware",
                        "NIKE",
                        "AIG"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods",
                        "technology",
                        "retail",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-05",
                "original_text": "Health Care Sector Update for 06/05/2019: RWLK, IFRX, SRRA, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "RWLK",
                        "IFRX",
                        "SRRA",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-05",
                "original_text": "Pfizer to Launch Several Drugs Despite Generic Headwinds",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Drugs",
                        "Launch",
                        "Generic Headwinds"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-05",
                "original_text": "10 Jaw-Dropping Numbers About Cancer Drug Development -- and What They Mean for Investors",
                "features": {
                    "keywords": [
                        "Cancer Drug Development",
                        "Investors",
                        "Numbers"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}